Literature DB >> 6413228

Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine.

S Nassif, E Kempf, B Cardo, L Velley.   

Abstract

The locus coeruleus of male rats was destroyed bilaterally by injection of 6-hydroxydopamine. Rats injected with the vehicle and normal rats served as controls. Starting 20 days after the lesion, the locomotor activity of all rats was measured for 5 min every day. For the first 6 days, the lesioned rats were significantly less active than control rats; from the 7th to the 15th day, on the other hand, the locomotor activity of the two groups of rats was the same. From the 16th day onwards, the sedative effect of small doses of clonidine (2.5-100 micrograms/kg) was measured in lesioned and control animals. In spite of an almost total loss of noradrenaline in the cerebral cortex and hippocampus and a 33% loss of noradrenaline in the brain-stem of the lesioned rats, the sedative effect of clonidine was the same as in the control rats. This result suggests that the sedation produced by clonidine is not dependent on presynaptically located alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413228     DOI: 10.1016/0014-2999(83)90363-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Suppression of desynchronized sleep through microinjection of the alpha 2-adrenergic agonist clonidine in the dorsal pontine tegmentum of the cat.

Authors:  G Tononi; M Pompeiano; C Cirelli
Journal:  Pflugers Arch       Date:  1991-06       Impact factor: 3.657

Review 2.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

3.  A study of the possible influence of central 5-HT function on clonidine-induced hypoactivity responses in mice.

Authors:  D J Heal; J Philpot
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Role of endogenous sleep-wake and analgesic systems in anesthesia.

Authors:  Jun Lu; Laura E Nelson; Nick Franks; Mervyn Maze; Nancy L Chamberlin; Clifford B Saper
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

6.  Antagonism of xylazine induced sedation by idazoxan in calves.

Authors:  T J Doherty; J A Ballinger; W N McDonell; P J Pascoe; A E Valliant
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

7.  Noradrenergic hyperactivity in hippocampus after partial denervation: pharmacological, behavioral, and electrophysiological studies.

Authors:  C Dyon-Laurent; A Hervé; S J Sara
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

8.  Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal.

Authors:  S Braune; M Albus; M Fröhler; T Höhn; G Scheibe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

9.  Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.